UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000010638
Receipt number R000012439
Scientific Title Phase II study of cetuximab rechallenge in the third-line therapy in patients with KRAS wild-type metastatic colorectal cancer
Date of disclosure of the study information 2013/05/07
Last modified on 2019/03/08 09:56:15

No. Disposal Last modified on Item of update
1 Insert 2013/05/02 18:28:18
2 Update 2013/05/03 08:29:07 Email
3 Update 2013/11/02 09:12:23 TEL
Email
4 Update 2013/11/20 11:44:21 TEL
Last name of contact person
Last name of contact person
Organization
Email
Institutions
5 Update 2013/11/20 12:58:29 Last name of contact person
Last name of contact person
6 Update 2016/05/02 09:20:33 Name of primary person or sponsor
Organization
7 Update 2016/11/15 13:23:27 Key inclusion criteria
8 Update 2016/11/15 13:25:27 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
9 Update 2019/03/08 09:56:15 Recruitment status
Date trial data considered complete
Date analysis concluded